Atalanta Sosnoff Capital LLC Has $93.10 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Atalanta Sosnoff Capital LLC trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 238,264 shares of the healthcare conglomerate’s stock after selling 820 shares during the quarter. UnitedHealth Group accounts for 2.2% of Atalanta Sosnoff Capital LLC’s portfolio, making the stock its 13th largest position. Atalanta Sosnoff Capital LLC’s holdings in UnitedHealth Group were worth $93,099,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of UNH. SignalPoint Asset Management LLC grew its stake in shares of UnitedHealth Group by 3.1% in the second quarter. SignalPoint Asset Management LLC now owns 786 shares of the healthcare conglomerate’s stock valued at $315,000 after acquiring an additional 24 shares in the last quarter. Davis Rea LTD. lifted its holdings in shares of UnitedHealth Group by 0.4% in the second quarter. Davis Rea LTD. now owns 6,782 shares of the healthcare conglomerate’s stock worth $2,716,000 after acquiring an additional 25 shares during the last quarter. Tandem Capital Management Corp ADV lifted its holdings in shares of UnitedHealth Group by 0.9% in the second quarter. Tandem Capital Management Corp ADV now owns 2,693 shares of the healthcare conglomerate’s stock worth $1,078,000 after acquiring an additional 25 shares during the last quarter. Foster Group Inc. lifted its holdings in shares of UnitedHealth Group by 1.0% in the second quarter. Foster Group Inc. now owns 2,466 shares of the healthcare conglomerate’s stock worth $987,000 after acquiring an additional 25 shares during the last quarter. Finally, Waters Parkerson & CO. LLC lifted its holdings in shares of UnitedHealth Group by 3.2% in the second quarter. Waters Parkerson & CO. LLC now owns 807 shares of the healthcare conglomerate’s stock worth $323,000 after acquiring an additional 25 shares during the last quarter. Institutional investors and hedge funds own 86.20% of the company’s stock.

A number of research analysts recently issued reports on the stock. SVB Leerink began coverage on shares of UnitedHealth Group in a report on Monday, September 27th. They issued an “outperform” rating and a $480.00 price objective for the company. Mizuho raised their price target on shares of UnitedHealth Group from $455.00 to $500.00 and gave the stock a “buy” rating in a report on Wednesday, November 10th. Morgan Stanley raised their price target on shares of UnitedHealth Group from $488.00 to $499.00 and gave the stock an “overweight” rating in a report on Friday, October 15th. BMO Capital Markets raised their price target on shares of UnitedHealth Group from $435.00 to $475.00 and gave the stock a “market perform” rating in a report on Monday, October 18th. Finally, Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $477.00 price target for the company in a report on Wednesday, October 27th. One equities research analyst has rated the stock with a hold rating, twenty-one have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of $477.35.

Shares of UnitedHealth Group stock opened at $450.16 on Thursday. UnitedHealth Group Incorporated has a 52-week low of $320.35 and a 52-week high of $466.00. The stock’s 50-day simple moving average is $430.47 and its 200 day simple moving average is $418.01. The stock has a market capitalization of $423.98 billion, a P/E ratio of 27.93, a P/E/G ratio of 1.75 and a beta of 0.85. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.77 and a current ratio of 0.77.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, October 14th. The healthcare conglomerate reported $4.52 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $4.41 by $0.11. UnitedHealth Group had a return on equity of 23.08% and a net margin of 5.52%. The business had revenue of $72.34 billion for the quarter, compared to analysts’ expectations of $71.24 billion. During the same period in the previous year, the business posted $3.51 EPS. The firm’s quarterly revenue was up 11.1% compared to the same quarter last year. Equities research analysts forecast that UnitedHealth Group Incorporated will post 18.84 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 14th. Shareholders of record on Monday, December 6th will be issued a dividend of $1.45 per share. This represents a $5.80 dividend on an annualized basis and a yield of 1.29%. The ex-dividend date is Friday, December 3rd. UnitedHealth Group’s payout ratio is presently 35.98%.

In other news, Director Stephen J. Hemsley sold 75,000 shares of the business’s stock in a transaction dated Monday, October 25th. The stock was sold at an average price of $448.72, for a total transaction of $33,654,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Richard T. Burke sold 2,500 shares of the business’s stock in a transaction dated Friday, September 17th. The stock was sold at an average price of $419.00, for a total value of $1,047,500.00. The disclosure for this sale can be found here. Insiders have sold a total of 82,500 shares of company stock valued at $36,855,125 in the last ninety days. Insiders own 0.55% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Read More: What is the G-20?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.